[go: up one dir, main page]

FR3074684B1 - NEW ANTI-STRESS PROCESS FOR THE SKIN INDUCED BY EXPOSURE TO BLUE LIGHT - Google Patents

NEW ANTI-STRESS PROCESS FOR THE SKIN INDUCED BY EXPOSURE TO BLUE LIGHT Download PDF

Info

Publication number
FR3074684B1
FR3074684B1 FR1761824A FR1761824A FR3074684B1 FR 3074684 B1 FR3074684 B1 FR 3074684B1 FR 1761824 A FR1761824 A FR 1761824A FR 1761824 A FR1761824 A FR 1761824A FR 3074684 B1 FR3074684 B1 FR 3074684B1
Authority
FR
France
Prior art keywords
mass
exposure
blue light
new anti
stress process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1761824A
Other languages
French (fr)
Other versions
FR3074684A1 (en
Inventor
Virginie Anchartechahar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SERDEX SAS
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Original Assignee
SERDEX SAS
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SERDEX SAS, Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA filed Critical SERDEX SAS
Priority to FR1761824A priority Critical patent/FR3074684B1/en
Priority to CN201880086107.9A priority patent/CN112105421A/en
Priority to EP18821722.8A priority patent/EP3720567A1/en
Priority to PCT/FR2018/052967 priority patent/WO2019110887A1/en
Priority to JP2020550919A priority patent/JP2021515028A/en
Publication of FR3074684A1 publication Critical patent/FR3074684A1/en
Application granted granted Critical
Publication of FR3074684B1 publication Critical patent/FR3074684B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

Procédé dans le but d'empêcher ou de ralentir l'apparition des signes du vieillissement de la peau humaine ou des lèvres générés par le stress oxydatif provoqué par l'exposition à la lumière bleue, ou bien d'éliminer lesdits signes, comprenant au moins une étape d'application sur la peau humaine ou sur les lèvres, d'une formulation cosmétique à usage topique (Fi) comprenant pour 100% de sa masse : (1) - De 90% à 99,5% massique d'au moins un excipient cosmétiquement acceptable, et (2) - De 0,5% à 10% massique d'une composition (C1), comprenant pour 100% de sa masse : a) - De 90% à 99% massique d'au moins une composition (C2) comprenant pour 100% de sa propre masse : (i) - De 40% à 80% massique d'au moins un composé de formule (I) : HO-[CH2-CH(OH)-CH2-O-]nH (I), dans laquelle n représente un nombre entier supérieur ou égal à 1 et inférieur ou égal à 6, et (ii) - De 20% à 60% massique d'eau b) - De 1 % à 10 % massique, plus particulièrement de 1 % à 5% massique, et encore plus particulièrement de 1% à 3% massique d'un extrait (EX) de la plante d'espèce Hedy-chium coronarium.Process for the purpose of preventing or slowing the appearance of signs of aging of human skin or lips generated by oxidative stress caused by exposure to blue light, or else of eliminating said signs, comprising at least a step of applying to human skin or to the lips, a cosmetic formulation for topical use (Fi) comprising, for 100% of its mass: (1) - From 90% to 99.5% by mass of at least a cosmetically acceptable excipient, and (2) - From 0.5% to 10% by mass of a composition (C1), comprising, for 100% of its mass: a) - From 90% to 99% by mass of at least one composition (C2) comprising, for 100% of its own mass: (i) - From 40% to 80% by mass of at least one compound of formula (I): HO- [CH2-CH (OH) -CH2-O- ] nH (I), in which n represents an integer greater than or equal to 1 and less than or equal to 6, and (ii) - From 20% to 60% by mass of water b) - From 1% to 10% by mass , more particularly from 1% to 5% by mass, and even more particularly ement from 1% to 3% by mass of an extract (EX) of the plant of the species Hedy-chium coronarium.

FR1761824A 2017-12-08 2017-12-08 NEW ANTI-STRESS PROCESS FOR THE SKIN INDUCED BY EXPOSURE TO BLUE LIGHT Active FR3074684B1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR1761824A FR3074684B1 (en) 2017-12-08 2017-12-08 NEW ANTI-STRESS PROCESS FOR THE SKIN INDUCED BY EXPOSURE TO BLUE LIGHT
CN201880086107.9A CN112105421A (en) 2017-12-08 2018-11-23 Novel methods for mitigating the effects of blue light-induced stress on skin
EP18821722.8A EP3720567A1 (en) 2017-12-08 2018-11-23 Novel method for reducing the effects of blue-light-induced stress on the skin
PCT/FR2018/052967 WO2019110887A1 (en) 2017-12-08 2018-11-23 Novel method for reducing the effects of blue-light-induced stress on the skin
JP2020550919A JP2021515028A (en) 2017-12-08 2018-11-23 A new way to reduce the effects of blue light-induced stress on the skin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1761824A FR3074684B1 (en) 2017-12-08 2017-12-08 NEW ANTI-STRESS PROCESS FOR THE SKIN INDUCED BY EXPOSURE TO BLUE LIGHT
FR1761824 2017-12-08

Publications (2)

Publication Number Publication Date
FR3074684A1 FR3074684A1 (en) 2019-06-14
FR3074684B1 true FR3074684B1 (en) 2020-08-07

Family

ID=62067609

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1761824A Active FR3074684B1 (en) 2017-12-08 2017-12-08 NEW ANTI-STRESS PROCESS FOR THE SKIN INDUCED BY EXPOSURE TO BLUE LIGHT

Country Status (5)

Country Link
EP (1) EP3720567A1 (en)
JP (1) JP2021515028A (en)
CN (1) CN112105421A (en)
FR (1) FR3074684B1 (en)
WO (1) WO2019110887A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230414564A1 (en) * 2020-12-11 2023-12-28 Shiseido Company, Ltd. Blue light oxidation inhibitor and screening method for same
WO2022157544A1 (en) * 2021-01-22 2022-07-28 Jlwh Pte Ltd Compositions and methods for recovering from blue-light (bl) induced pigmentation, oxidative stress and inflammation
CN113101255A (en) * 2021-04-19 2021-07-13 广东梵蜜琳生物科技有限公司 Anti-premature composition and preparation method and application thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787457B1 (en) * 1998-12-18 2004-12-17 Seppic Sa NEW INVERSE LATEX ELECTROLYTE STABLE, PREPARATION METHOD AND USE IN COSMETICS
EP1010708B1 (en) * 1998-12-18 2004-03-31 Societe D'exploitation De Produits Pour Les Industries Chimiques, S.E.P.P.I.C. Use in cosmetics of an inverse latex stable against electrolytes
AU2002251801A1 (en) 2001-01-19 2002-07-30 Johnson And Johnson Consumer Companies, Inc. Composition containing hedychium extract and use thereof
WO2006053415A1 (en) 2004-11-18 2006-05-26 Biopharmacopae Design International Inc. Plant extract having matrix metalloprotease inhibiting activity and dermatological uses thereof
FR2895257A1 (en) 2005-12-22 2007-06-29 Oreal Use of lipophilic antioxidant as active principle for preparing cosmetic and/or dermatological composition to maintain and/or reinforce the protective and reparative native function of lipophilic structures of eye contour
FR2948285B1 (en) * 2009-07-27 2011-09-23 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic OIL-IN-WATER EMULSION WITH IMPROVED SENSORY PROPERTIES
BRPI0905586A8 (en) * 2009-12-21 2017-10-10 Antonio Meneghetti Ind E Com De Artigos De Vestuario Ltda COMPOSITION AND USE OF COSMETIC COMPOUNDS FOR DERMATOLOGICAL APPLICATION
KR20140101967A (en) * 2013-02-13 2014-08-21 한국임업진흥원 Eye serum comprising wood-cultivated ginseng extract and Manufacturinf method thereof
CN103494737B (en) * 2013-09-27 2015-04-22 浙江树人大学 Cosmetic preparation using ginger flower as anti-ageing and skin-protecting factor and preparation method of cosmetic preparation
FR3048881B1 (en) 2016-03-16 2020-03-27 Jafer Enterprises R&D, S.L. PEPTIDE AND OSIDIC HYDROLYSAT OF COCOA BEANS, COSMETIC COMPOSITIONS COMPRISING SAME AND THEIR COSMETIC USES
EP3342465A1 (en) * 2016-12-30 2018-07-04 Bayer Consumer Care AG Hedychium extract and compositions thereof and their use in the treatment of skin affected by harmful environmental influences

Also Published As

Publication number Publication date
JP2021515028A (en) 2021-06-17
CN112105421A (en) 2020-12-18
EP3720567A1 (en) 2020-10-14
WO2019110887A1 (en) 2019-06-13
FR3074684A1 (en) 2019-06-14

Similar Documents

Publication Publication Date Title
FR3074684B1 (en) NEW ANTI-STRESS PROCESS FOR THE SKIN INDUCED BY EXPOSURE TO BLUE LIGHT
EA202092001A1 (en) COMPOUNDS FOR TREATMENT OF GENTINGTON'S DISEASE
EA202092899A1 (en) HETEROARYL COMPOUNDS FOR THE TREATMENT OF GENTINGTON'S DISEASE
ZA202201364B (en) Deuterated compounds for use in the treatment of cancer
BRPI0809164B8 (en) COMPOSITION FOR TOPICAL ADMINISTRATION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID COMPOSITION
MX2017010220A (en) FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS WITH CONTROLLED ABSORPTION PROFILE.
MX2017002451A (en) Compounds and methods for inhibiting histone demethylases.
BR112013003847A2 (en) methods of treating moderate cognitive impairment (mci) and related disorders
HRP20210323T1 (en) Sunscreen composition
EA202090068A1 (en) COMPOUNDS INFLUENCING PIGMENT SYNTHESIS AND THEIR APPLICATION FOR TREATMENT OF BACTERIAL DISEASES
KR102432796B9 (en) Composition for preventing and treating skeletal muscle-related diseases containing compound 2 isolated from alder extract
BR112023005226A2 (en) COMPOSITION TO PROMOTE THE SKIN MICROBIOME
RU2016146938A (en) COMPOSITIONS CONTAINING POLYMER SULFUR AND METHODS OF APPLICATION
MX2020004930A (en) Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors.
MX2022011203A (en) 9-aminomethyl minocycline compounds and uses thereof.
SA519402556B1 (en) Cosmetic skincare compositions
EA202090666A1 (en) APPLICATION OF BENZOATE-CONTAINING COMPOSITION FOR TREATMENT OF GLYCINE ENCEPHALOPATHY
MX2021012353A (en) Topical cosmetic composition and uses thereof.
AR088247A1 (en) COMPOSITION TO COLOR SKIN AND METHOD TO COLOR SKIN
BR112023000817A2 (en) ISOINDOLINE DERIVATIVE CONTAINING SULFUR, AND METHOD OF PREPARATION OF THE SAME AND MEDICAL USE OF THE SAME
EA202090470A1 (en) COMPOSITION FOR PERSONAL CARE
CL2021000660A1 (en) Iron chelating compounds to treat aesthetic skin conditions
PH12020551117A1 (en) Compositions for preventing or treating uveitis
BR112017010740A2 (en) ? compound, cosmetic composition, use and method for cosmetic treatment?
FR3067938B1 (en) USE OF A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION AGAINST THE EFFECTS INDUCED BY BLUE LIGHT

Legal Events

Date Code Title Description
PLSC Publication of the preliminary search report

Effective date: 20190614

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8